JP2009534331A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009534331A5 JP2009534331A5 JP2009505766A JP2009505766A JP2009534331A5 JP 2009534331 A5 JP2009534331 A5 JP 2009534331A5 JP 2009505766 A JP2009505766 A JP 2009505766A JP 2009505766 A JP2009505766 A JP 2009505766A JP 2009534331 A5 JP2009534331 A5 JP 2009534331A5
- Authority
- JP
- Japan
- Prior art keywords
- hpv
- composition
- polypeptide
- amino acid
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06360013 | 2006-04-21 | ||
| PCT/EP2007/003367 WO2007121894A2 (en) | 2006-04-21 | 2007-04-17 | Hpv-18-based papillomavirus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009534331A JP2009534331A (ja) | 2009-09-24 |
| JP2009534331A5 true JP2009534331A5 (https=) | 2010-06-03 |
Family
ID=38230081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009505766A Withdrawn JP2009534331A (ja) | 2006-04-21 | 2007-04-17 | Ｈｐｖ‐１８を主体とするパピローマウイルスワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100055069A1 (https=) |
| EP (1) | EP2013229A2 (https=) |
| JP (1) | JP2009534331A (https=) |
| KR (1) | KR20090005010A (https=) |
| CN (1) | CN101426810A (https=) |
| AU (1) | AU2007241405A1 (https=) |
| BR (1) | BRPI0710242A2 (https=) |
| CA (1) | CA2649555A1 (https=) |
| IL (1) | IL193566A0 (https=) |
| MX (1) | MX2008013489A (https=) |
| WO (1) | WO2007121894A2 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2670471A1 (en) | 2006-11-22 | 2008-06-05 | Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| ES2725450T3 (es) | 2007-07-02 | 2019-09-24 | Etubics Corp | Métodos y composiciones para la producción de un vector adenoviral para su uso en vacunaciones múltiples |
| CN102007145A (zh) | 2008-02-14 | 2011-04-06 | 百时美施贵宝公司 | 基于结合egfr的工程化蛋白质的靶向治疗剂 |
| PE20091931A1 (es) | 2008-05-22 | 2009-12-31 | Bristol Myers Squibb Co | Proteinas de dominio de armazon basadas en fibronectina multivalentes |
| TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子 |
| CA2653478A1 (en) | 2009-01-23 | 2010-07-23 | Gregg Martin | Automated wash system for industrial vehicles |
| RU2011148791A (ru) | 2009-05-12 | 2013-06-20 | Трансген Са | Иммортализованные линии клеток птиц и их применение |
| IN2012DN01577A (https=) | 2009-07-21 | 2015-06-05 | Transgene Sa | |
| TW201138808A (en) | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
| ES2573108T3 (es) | 2010-05-26 | 2016-06-06 | Bristol-Myers Squibb Company | Proteínas de armazón a base de fibronectina que tienen estabilidad mejorada |
| WO2014031178A1 (en) | 2012-08-24 | 2014-02-27 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| TWI690322B (zh) | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
| WO2014165291A1 (en) | 2013-03-12 | 2014-10-09 | The Trustees Of The University Of Pennsylvania | Improved vaccines for human papilloma virus and methods for using the same |
| EP3129401B1 (en) | 2014-03-20 | 2019-06-12 | Bristol-Myers Squibb Company | Serum albumin-binding fibronectin type iii domains |
| AU2015357225B2 (en) | 2014-12-01 | 2020-04-09 | Transgene Sa | Stable liquid vaccinia virus formulations |
| KR102193635B1 (ko) | 2015-01-09 | 2020-12-21 | 이투빅스 코포레이션 | 복합 면역요법을 위한 방법 및 조성물 |
| CA2973109A1 (en) | 2015-01-09 | 2016-07-14 | Etubics Corporation | Methods and compositions for ebola virus vaccination |
| WO2016172249A1 (en) * | 2015-04-20 | 2016-10-27 | Etubics Corporation | Methods and compositions for combination immunotherapy |
| EP3708580B1 (en) | 2015-09-23 | 2023-11-01 | Bristol-Myers Squibb Company | Fast-off rate serum albumin binding fibronectin type iii domains |
| CN110603058A (zh) | 2017-05-15 | 2019-12-20 | 扬森疫苗与预防公司 | 含有病毒的稳定组合物 |
| KR102658198B1 (ko) | 2017-05-15 | 2024-04-16 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정한 바이러스 함유 조성물 |
| EP3847246A1 (en) | 2018-09-06 | 2021-07-14 | Bavarian Nordic A/S | Storage improved poxvirus compositions |
| WO2020117715A1 (en) | 2018-12-03 | 2020-06-11 | Board Of Regents, The University Of Texas System | Oligo-benzamide analogs and their use in cancer treatment |
| US20230114464A1 (en) | 2020-03-12 | 2023-04-13 | Bavarian Nordic A/S | Conditions Improving Poxvirus Stability |
| CN117965634B (zh) * | 2024-04-01 | 2024-07-12 | 北京唯源立康生物科技股份有限公司 | 一种hsv-1病毒载体及其应用 |
| CN119752807A (zh) * | 2025-03-10 | 2025-04-04 | 成都迈科康生物科技有限公司 | 一种表达hpv18型e6蛋白的单克隆细胞及其在构建hpv肿瘤动物模型中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
| FR2766091A1 (fr) * | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
| AUPP030997A0 (en) * | 1997-11-10 | 1997-12-04 | Clift, Vaughan | Intra aural integrated vital signs monitor |
| WO2002077012A2 (en) * | 2001-03-23 | 2002-10-03 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Human papilloma virus immunoreative peptides |
| DE60332377D1 (de) * | 2002-10-21 | 2010-06-10 | Eisai Inc | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden |
| US7160252B2 (en) * | 2003-01-10 | 2007-01-09 | Medtronic, Inc. | Method and apparatus for detecting respiratory disturbances |
-
2007
- 2007-04-17 AU AU2007241405A patent/AU2007241405A1/en not_active Abandoned
- 2007-04-17 CA CA002649555A patent/CA2649555A1/en not_active Abandoned
- 2007-04-17 CN CNA2007800143855A patent/CN101426810A/zh active Pending
- 2007-04-17 BR BRPI0710242-9A patent/BRPI0710242A2/pt not_active IP Right Cessation
- 2007-04-17 EP EP07724304A patent/EP2013229A2/en not_active Withdrawn
- 2007-04-17 KR KR1020087025574A patent/KR20090005010A/ko not_active Ceased
- 2007-04-17 JP JP2009505766A patent/JP2009534331A/ja not_active Withdrawn
- 2007-04-17 US US12/297,998 patent/US20100055069A1/en not_active Abandoned
- 2007-04-17 WO PCT/EP2007/003367 patent/WO2007121894A2/en not_active Ceased
- 2007-04-17 MX MX2008013489A patent/MX2008013489A/es not_active Application Discontinuation
-
2008
- 2008-08-20 IL IL193566A patent/IL193566A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009534331A5 (https=) | ||
| JP2009534332A5 (https=) | ||
| IL215599A (en) | A nucleic acid-encoding vector for proteins 1e and 2e of the papilloma virus | |
| RU2008145712A (ru) | Вакцина против папилломовирусной инфекции на основе вируса папиломы человека впч-16 | |
| JP2010516287A5 (https=) | ||
| RU2009144898A (ru) | Векторы для множественной генной экспрессии | |
| JP2010526547A5 (https=) | ||
| US8147839B2 (en) | Fusion proteins of HIV regulatory/accessory proteins | |
| US20100055069A1 (en) | Hpv-18-based papillomavirus vaccines | |
| JP2018148890A5 (https=) | ||
| TR201900695T4 (en) | HPV / CYAA-BASED CHEMICAL PROTEINS AND THEIR USE IN INDUCING IMMUNE RESPONSE AGAINST HPV INFECTION AND HPV-INDUCED DISASTER. | |
| RU2008106481A (ru) | Композиция для лечения и предупреждения папилломавирусной инфекции человека на основе белка l1 и пептидов белка е7 |